Brief: Transcode Therapeutics Reports Positive Preclinical Results With Its Immunotherapy Candidate In Melanoma

Transcode Therapeutics

31/01/2023 22:37

Jan 31 (Reuters) - Transcode Therapeutics Inc  RNAZ.O :
    * TRANSCODE THERAPEUTICS REPORTS POSITIVE PRECLINICAL
RESULTS WITH
ITS IMMUNOTHERAPY CANDIDATE, TTX-RIGA, IN MELANOMA
    * TRANSCODE THERAPEUTICS INC - REPORTED SUCCESSFUL
PRECLINICAL
PROOF-OF-MECHANISM STUDIES WITH ITS IMMUNOTHERAPY CANDIDATE,
TTX-RIGA, IN MELANOMA.

Source text for Eikon:  ID:nGNX1y8k9z 
Further company coverage:  RNAZ.O 
 ((Reuters.Briefs@thomsonreuters.com;))